Works in Vaccines, 2024, Vol 12, Issue 11
Results: 98
Association Between Influenza Vaccine and Immune Thrombocytopenia: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1298, doi. 10.3390/vaccines12111298
- By:
- Publication type:
- Article
Preliminary Study on Type I Interferon as a Mucosal Adjuvant for Human Respiratory Syncytial Virus F Protein.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1297, doi. 10.3390/vaccines12111297
- By:
- Publication type:
- Article
Childhood Mandatory Vaccinations: Current Situation in European Countries and Changes Occurred from 2014 to 2024.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1296, doi. 10.3390/vaccines12111296
- By:
- Publication type:
- Article
Incidence of SARS-CoV-2 Infection Among European Healthcare Workers and Effectiveness of the First Booster COVID-19 Vaccine, VEBIS HCW Observational Cohort Study, May 2021–May 2023.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1295, doi. 10.3390/vaccines12111295
- By:
- Publication type:
- Article
Multiparameter Flow Cytometric Analysis of the Conventional and Monocyte-Derived DC Compartment in the Murine Spleen.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1294, doi. 10.3390/vaccines12111294
- By:
- Publication type:
- Article
Human Papillomavirus (HPV) Vaccination: Progress, Challenges, and Future Directions in Global Immunization Strategies.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1293, doi. 10.3390/vaccines12111293
- By:
- Publication type:
- Article
Sindbis Virus Replicon-Based SARS-CoV-2 and Dengue Combined Vaccine Candidates Elicit Immune Responses and Provide Protective Immunity in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1292, doi. 10.3390/vaccines12111292
- By:
- Publication type:
- Article
Human Papillomavirus-Related Cancer Vaccine Strategies.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1291, doi. 10.3390/vaccines12111291
- By:
- Publication type:
- Article
Nanoparticles as Delivery Systems for Antigenic Saccharides: From Conjugation Chemistry to Vaccine Design.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1290, doi. 10.3390/vaccines12111290
- By:
- Publication type:
- Article
Impact of Immunosenescence on Vaccine Immune Responses and Countermeasures.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1289, doi. 10.3390/vaccines12111289
- By:
- Publication type:
- Article
First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1288, doi. 10.3390/vaccines12111288
- By:
- Publication type:
- Article
Engineering Escherichia coli -Derived Nanoparticles for Vaccine Development.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1287, doi. 10.3390/vaccines12111287
- By:
- Publication type:
- Article
A Comprehensive Evaluation of the HPV Neutralizing Antibodies in Guangzhou, China: A Comparative Study on Various HPV Vaccines.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1286, doi. 10.3390/vaccines12111286
- By:
- Publication type:
- Article
Newcastle Disease Virus Expressing Cap Gene of Porcine Circovirus Type 2 Confers Protection in Mice and Induced Long-Lasting Neutralizing Antibodies in Pigs.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1285, doi. 10.3390/vaccines12111285
- By:
- Publication type:
- Article
Factors Predicting COVID-19 Vaccine Effectiveness and Longevity of Humoral Immune Responses.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1284, doi. 10.3390/vaccines12111284
- By:
- Publication type:
- Article
Correction: Huang et al. Next Generation of Computationally Optimized Broadly Reactive HA Vaccines Elicited Cross-Reactive Immune Responses and Provided Protection against H1N1 Virus Infection. Vaccines 2021, 9 , 793.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Milk-Derived Extracellular Vesicles: A Novel Perspective on Comparative Therapeutics and Targeted Nanocarrier Application.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1282, doi. 10.3390/vaccines12111282
- By:
- Publication type:
- Article
The Immunologic Downsides Associated with the Powerful Translation of Current COVID-19 Vaccine mRNA Can Be Overcome by Mucosal Vaccines.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1281, doi. 10.3390/vaccines12111281
- By:
- Publication type:
- Article
Beyond Suppression: Peripheral T Cell Responses to Vaccination in Inflammatory Bowel Disease Patients Undergoing Anti-Tumor-Necrosis-Factor Therapy.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1280, doi. 10.3390/vaccines12111280
- By:
- Publication type:
- Article
The Health and Economic Effects of PCV15 and PCV20 During the First Year of Life in the US.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1279, doi. 10.3390/vaccines12111279
- By:
- Publication type:
- Article
Host Innate and Adaptive Immunity Against African Swine Fever Virus Infection.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1278, doi. 10.3390/vaccines12111278
- By:
- Publication type:
- Article
Heterogeneous Associations Between Pandemic-Induced Socioeconomic Hardships and COVID-19 Vaccine Uptake by Sexual Orientation and Gender Identity: A Nationally Representative Analysis in the United States.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1277, doi. 10.3390/vaccines12111277
- By:
- Publication type:
- Article
Hepatitis A Seroprevalence Among HIV-Exposed and Unexposed Pediatric Populations in South Africa.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1276, doi. 10.3390/vaccines12111276
- By:
- Publication type:
- Article
An Optimised Live Attenuated Influenza Vaccine Ferret Efficacy Model Successfully Translates H1N1 Clinical Data.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1275, doi. 10.3390/vaccines12111275
- By:
- Publication type:
- Article
Immunity Dynamics of Neisseria meningitidis Serogroups ACYW from Birth and Following Vaccination.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1274, doi. 10.3390/vaccines12111274
- By:
- Publication type:
- Article
Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate Cancer.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1273, doi. 10.3390/vaccines12111273
- By:
- Publication type:
- Article
Design of a Glycoconjugate Vaccine Against Salmonella Paratyphi A.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1272, doi. 10.3390/vaccines12111272
- By:
- Publication type:
- Article
Efficacy of Feed-Based Genome-Free Bacterial Vaccine Against Aeromonas hydrophila Infection in Red Tilapia (Oreochromis sp.).
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1271, doi. 10.3390/vaccines12111271
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors and Vaccination: Assessing Safety, Efficacy, and Synergistic Potential.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1270, doi. 10.3390/vaccines12111270
- By:
- Publication type:
- Article
The Impact of Palivizumab for Respiratory Syncytial Virus Prophylaxis on Preschool Childhood Asthma.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1269, doi. 10.3390/vaccines12111269
- By:
- Publication type:
- Article
Oral Administration of Zinc Sulfate with Intramuscular Foot-and-Mouth Disease Vaccine Enhances Mucosal and Systemic Immunity.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1268, doi. 10.3390/vaccines12111268
- By:
- Publication type:
- Article
A Cap-Optimized mRNA Encoding Multiepitope Antigen ESAT6 Induces Robust Cellular and Humoral Immune Responses Against Mycobacterium tuberculosis.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1267, doi. 10.3390/vaccines12111267
- By:
- Publication type:
- Article
Understanding Parental Decision-Making and Determinants of COVID-19 Vaccination for Children in Vietnam: A Cross-Sectional Online Survey.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1266, doi. 10.3390/vaccines12111266
- By:
- Publication type:
- Article
Measuring the Vaccine Success Index: A Framework for Long-Term Economic Evaluation and Monitoring in the Case of Rotavirus Vaccination.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1265, doi. 10.3390/vaccines12111265
- By:
- Publication type:
- Article
Association of COVID-19 Vaccine Intake with Diagnosis, Hospitalization, and Oxygenation/Ventilation: A Longitudinal Analysis, 2021–2022, Japan.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1264, doi. 10.3390/vaccines12111264
- By:
- Publication type:
- Article
Oceanic Breakthroughs: Marine-Derived Innovations in Vaccination, Therapy, and Immune Health.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1263, doi. 10.3390/vaccines12111263
- By:
- Publication type:
- Article
Immunogenicity Assessment of a 14-Valent Human Papillomavirus Vaccine Candidate in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1262, doi. 10.3390/vaccines12111262
- By:
- Publication type:
- Article
Resurgence of Pertussis in the Gyeongnam Region of South Korea in 2023 and 2024.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1261, doi. 10.3390/vaccines12111261
- By:
- Publication type:
- Article
Does Tobacco Smoking Affect Vaccine-Induced Immune Response? A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1260, doi. 10.3390/vaccines12111260
- By:
- Publication type:
- Article
Influenza Vaccination Coverage and Influencing Factors in Type 2 Diabetes in Mainland China: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1259, doi. 10.3390/vaccines12111259
- By:
- Publication type:
- Article
Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1258, doi. 10.3390/vaccines12111258
- By:
- Publication type:
- Article
Lessons from Recent Measles Post-Campaign Coverage Surveys Worldwide.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1257, doi. 10.3390/vaccines12111257
- By:
- Publication type:
- Article
SARS-CoV-2-Neutralizing Antibodies.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1256, doi. 10.3390/vaccines12111256
- By:
- Publication type:
- Article
Safety and Immunogenicity of Intranasal Razi Cov Pars as a COVID-19 Booster Vaccine in Adults: Promising Results from a Groundbreaking Clinical Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1255, doi. 10.3390/vaccines12111255
- By:
- Publication type:
- Article
Hepatitis B Virus-Related Cirrhosis and Hepatocellular Carcinoma Hospital Discharge Rates from 2005 to 2021 in Spain: Impact of Universal Vaccination.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1254, doi. 10.3390/vaccines12111254
- By:
- Publication type:
- Article
EMSIG: Uncovering Factors Influencing COVID-19 Vaccination Across Different Subgroups Characterized by Embedding-Based Spatial Information Gain.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1253, doi. 10.3390/vaccines12111253
- By:
- Publication type:
- Article
Exposure to Pollutants and Vaccines' Effectiveness: A Systematic Review.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1252, doi. 10.3390/vaccines12111252
- By:
- Publication type:
- Article
Systematic Review on Influenza Burden in Emerging Markets in 2018–2023—An Evidence Update to Guide Influenza Vaccination Recommendations.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1251, doi. 10.3390/vaccines12111251
- By:
- Publication type:
- Article
Multi-Epitopic Peptide Vaccine Against Newcastle Disease Virus: Molecular Dynamics Simulation and Experimental Validation.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1250, doi. 10.3390/vaccines12111250
- By:
- Publication type:
- Article
Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple Myeloma.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1249, doi. 10.3390/vaccines12111249
- By:
- Publication type:
- Article